Sun Qiquan, Yang Yang
Department of Renal Transplantation, The Third Affiliated Hospital, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou 510630, China.
Clin Dev Immunol. 2013;2013:859761. doi: 10.1155/2013/859761. Epub 2013 Oct 8.
Antibody-mediated rejection (AMR) is an important cause of graft loss after organ transplantation. It is caused by anti-donor-specific antibodies especially anti-HLA antibodies. C4d had been regarded as a diagnosis marker for AMR. Although most early AMR episodes can be successfully controlled or reversed, late and chronic AMR remains the leading cause of late graft loss. The strategies which work in early AMR have limited effect on late/chronic episodes. Here, we reviewed the lines of evidence that late/chronic AMR is the leading cause of late graft loss, characteristics of late AMR, and current strategies in managing late/chronic AMR. More effort should be put on the management of late/chronic AMR to make a better long term graft survival.
抗体介导的排斥反应(AMR)是器官移植后移植物丢失的重要原因。它由抗供体特异性抗体尤其是抗HLA抗体引起。C4d一直被视为AMR的诊断标志物。尽管大多数早期AMR发作可以成功控制或逆转,但晚期和慢性AMR仍然是晚期移植物丢失的主要原因。在早期AMR中有效的策略对晚期/慢性发作的效果有限。在此,我们综述了晚期/慢性AMR是晚期移植物丢失的主要原因的证据、晚期AMR的特征以及当前管理晚期/慢性AMR的策略。应更加努力管理晚期/慢性AMR,以实现更好的长期移植物存活。